Find clinical trials for Triple Negative Breast Cancer in Birmingham, AL
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Triple Negative Breast Cancer trials near Birmingham, AL, USA:
Veliparib and Lapatinib, given to participants with metastatic triple negative breast cancer that have undergone ...
Birmingham, Alabama, United States
This is a 3-arm study stratified by plasma ctDNA. Patients with residual TNBC disease after pre-operative therapy will be assigned to 1 of 3 Arms bas...
Phase 2
Birmingham, Alabama, United States and 12 other locations
avelumab with sacituzumab govitecan works in treating patients with triple negative breast cancer that is stage I...
Phase 2
Birmingham, Alabama, United States and 11 other locations
or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after su...
Phase 3
Birmingham, Alabama, United States of America and 166 other locations
or metastatic (spread to other parts of the body); triple negative breast cancer; epithelial ovarian cancer...
Phase 2
Birmingham, Alabama, United States and 55 other locations
monotherapy versus olaparib in combination with an inhibitor of WEE1 (adavosertib \[AZD1775\]) in second or third line setting in patients with Triple...
Phase 2
Birmingham, Alabama, United States and 140 other locations
This study will test the safety of a drug called PF-08046054/SGN-PDL1V alone and with pembrolizumab in participants with solid tumors. It wi ...
Phase 1
Birmingham, Alabama, United States and 23 other locations
in treating advanced or metastatic androgen receptor-positive (AR+) triple negative breast cancer (TNBC) or estro ...
Phase 2
Birmingham, Alabama, United States and 11 other locations
tumors....
Phase 1
Birmingham, Alabama, United States and 7 other locations
to evaluate safety and efficacy of an antibody drug conjugate U3-1402 (patritumab deruxtecan) in patients with locally advanced or metastatic breast...
Phase 2
Birmingham, Alabama, United States and 10 other locations
Clinical trials
Research sites
Resources
Legal